CRISPR THERAPEUTICS AG's ticker is CRSP and the CUSIP is H17182108. A total of 84 filers reported holding CRISPR THERAPEUTICS AG in Q4 2017. The put-call ratio across all filers is 0.44 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $609,000 | +48.5% | 10,000 | 0.0% | 0.41% | +31.4% |
| Q3 2019 | $410,000 | -13.0% | 10,000 | 0.0% | 0.32% | -2.8% |
| Q2 2019 | $471,000 | +31.9% | 10,000 | 0.0% | 0.32% | +27.1% |
| Q1 2019 | $357,000 | +24.8% | 10,000 | 0.0% | 0.26% | +0.4% |
| Q4 2018 | $286,000 | -35.6% | 10,000 | 0.0% | 0.25% | -12.4% |
| Q3 2018 | $444,000 | -24.5% | 10,000 | 0.0% | 0.29% | -30.5% |
| Q2 2018 | $588,000 | +28.7% | 10,000 | 0.0% | 0.42% | +20.2% |
| Q1 2018 | $457,000 | -35.1% | 10,000 | -66.7% | 0.35% | -37.4% |
| Q4 2017 | $704,000 | – | 30,000 | – | 0.55% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Gilfoyle Management LLC | 150 | $6,376 | 12.96% |
| Versant Venture Management, LLC | 498,558 | $22,629,548 | 12.03% |
| NEA Management Company, LLC | 1,587,854 | $72,072,693 | 5.57% |
| ARK Investment Management | 7,163,118 | $325,133,913 | 2.49% |
| Nikko Asset Management Americas, Inc. | 3,465,470 | $157,263,029 | 1.88% |
| Integral Health Asset Management, LLC | 275,000 | $12,482,250 | 1.73% |
| Merlin Capital, Inc | 9,092 | $412,686 | 1.54% |
| Del-Sette Capital Management, LLC | 33,977 | $1,542,216 | 1.52% |
| Green Alpha Advisors, LLC | 34,880 | $1,583,203 | 1.22% |
| Ikarian Capital, LLC | 2,039 | $9,255,021 | 1.11% |